Find key information for shareholders in 4D pharma plc

Registered office

4D pharma plc
9 Bond Court
Leeds LS1 2JZ

Share information

There are 65,493,842 ordinary shares in issue. There are no ordinary shares held in treasury. Therefore, the total number of voting rights in the Company is 65,493,842.

Please view the table below for the interests of shareholders of 3% or more which have been notified to the Company. Other directors who are also shareholders include Thomas Engelen (0.8%).

Insofar as the Company is aware, the percentage of the Company’s issued ordinary shares that is not in public hands is 72.1%

There are no restrictions as to the transfer of ordinary shares.

Major shareholders

Ordinary shares held %
Woodford Investment Management 17,514,561 26.74%
Invesco Asset Management Limited 9,163,617 13.99%
David Robert Norwood 7,123,725 10.88%
Duncan Joseph Peyton 6,455,075
Alexander James Stevenson
6,413,136 9.79%
Janus Henderson Group plc 3,425,648 5.23%
Lansdowne Partners
3,000,000 4.58%

This information was last updated on 30 May 2019.

Meetings and voting

Advisers and registrars

Zeus Capital Limited
82 King Street
Manchester M2 4WQ


10 Old Burlington Street
London W1S 3AG

Bryan Garnier & Co. Limited

Beaufort House

15 St. Botolph Street

London EC3A 7BB

3 Hardman Street
Manchester M3 3HF

Link Asset Services
The Registry
34 Beckenham Road
Kent BR3 4TU